Is the blood B-cell subset profile diagnostic for Sjögren syndrome?

Annals of the Rheumatic Diseases

Volumn 68, Issue 9, 2009, Pages 1447-1452

  Binard, A ^a   Le Pottier, L ^a   Devauchelle Pensec, V ^a   Saraux, A ^a   Youinou, P ^a,b   Pers, J O ^a  

^a UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^b UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTE SUBSETS; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOPHENOTYPING; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SJOGREN'S SYNDROME;

EID: 69949181085     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.096172     Document Type: Article

References (23)

1. Moutsopoulos HM. Sjögren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 1994;72:162-165
2. Binard A, Devauchelle V, Fautrel B, Jousse S, Youinou P, Saraux A. Epidemiology of Sjögren's syndrome: where are we now? Clin Exp Rheumatol 2007;25:1-4.
3. Pijpe J, van Imhoff GW, Spijkervet FK, Roodenburg JL, Wolbink GJ, Mansour K, et al. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study. Arthritis Rheum 2005;52:2740-2750 (Pubitemid 41369102)
4. Devauchelle V, Pennec Y, Morvan J, Pers JO, Daridon C, Jousse S, et al. Improvement of Sjögren's syndrome after two infusions of rituximab. Arthritis Rheum 2007;57:310-317
5. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-347
6. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the AECG. Ann Rheum Dis 2002;61:554-558
7. Dörner T, Lipsky PE. Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome. Arthritis Res 2002;4:360-371 (Pubitemid 35364004)
8. Looney RJ. Will targeting B cells be the answer for Sjögren's syndrome? Arthritis Rheum 2007;56:1371-1377
9. Jonsson R, Nginamau E, Szyszko E, Brokstad KA. Role of B cells in Sjögren's syndrome from benign lymphoproliferation to overt malignancy. Front Biosci 2007;12:2159-2170
10. Youinou P, Daridon C, Steinfeld S, Pers JO. A case for B cells in the pathogenesis of Sjögren's syndrome. Current Trends Immunol 2008;8:15-25.
11. Pascual V, Liu YJ, Magalski A, de Bouteiller O, Banchereau J, Capra JD. Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med 1994;180:329-339 (Pubitemid 24181081)
12. Hansen A, Odendahl M, Reiter K, Jacobi AM, Feist E, Scholze J, et al. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2002;46:2160-2171 (Pubitemid 34894773)
13. d'Arbonneau F, Pers JO, Devauchelle V, Pennec Y, Saraux A, Youinou P. BAFFinduced changes in BCR-containing lipid rafts in Sjögren's syndrome. Arthritis Rheum 2006;54:115-126
14. Bohnhorst JO, Bjorgan MB, Thoen JE, Natvig JB, Thompson KM. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B-cell subpopulations in patients with primary Sjögren's syndrome. J Immunol 2001;167:3610-3618
15. Daridon C, Pers JO, Devauchelle V, Martins-Carvalho C, Hutin P, Pennec YL, et al. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2006;54:2280-2288 (Pubitemid 44051085)
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324
17. Hochberg MC. Updating the ACR revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
18. Manthorpe R. Sjögren's syndrome criteria. Ann Rheum Dis 2002;61:482-484
19. Vitali C. Classification criteria for Sjögren's syndrome. Ann Rheum Dis 2003;62:94-95
20. Dougados M, Gossec L. Classification criteria for rheumatic diseases: why and how? Arthritis Rheum 2007;57:1112-1115
21. De Vita S, Boiocchi M, Sorrentino D, Carbone A, Avellini C, Dolcetti R, et al. Characterization of prelymphomatous stages of B-cell lymphoproliferation in Sjögren's syndrome. Arthritis Rheum 1997;40:318-331 (Pubitemid 27114096)
22. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002;46:741-747
23. Pers JO, Devauchelle V, Daridon C, Bendaoud B, Le Berre R, Bordron A, et al. BAFFmodulated repopulation of B cells in the blood and salivary glands of RTX-treated patients with Sjögren's syndrome. Arthritis Rheum 2007;56:1464-1477 (Pubitemid 46764075)